生物标志物概况在引起的与未引起的深静脉血栓塞
Isabela Rodrigues Tavares1,2, Roberto Augusto Caffaro1, Maria Fernanda Portugal3
1Department of Vascular Surgery, Santa Casa de São Paulo School of Medical Sciences, São Paulo, SP, Brazil.
概括
这项研究探讨了静脉血栓塞栓症 (VTE) 的分子标记物,在深静脉血栓症 (DVT) 患者中发现了高水平. 然而,在被挑和未被挑的DVT组中,没有显著的生物标志物差异.
科学领域:
- 生物化学 生物化学
- 血液学 血液学 血液学
- 医学诊断 医学诊断 医学诊断
背景情况:
- 静脉血栓塞栓症 (VTE),包括深静脉血栓症 (DVT) 和肺栓塞 (PE),对健康造成重大负担.
- 在风险评估和治疗方面,区分被诱导和未被诱导的DVT至关重要,但当前的方法存在局限性.
- 分子标记物可以提高诊断精度,并有助于确定抗凝治疗的持续时间.
研究的目的:
- 研究特定分子标记在挑起和未挑起深静脉血栓症 (DVT) 之间的区别中的实用性.
- 评估与健康对照组相比,患有DVT的患者30天内生物标志物度的变化.
- 探索使用分子标记物进行个性化血栓形成评估的潜力.
主要方法:
- 一项初步的,开放的,前性队列研究,涉及15名DVT患者 (10名被诱导,5名未被诱导) 和健康对照.
- 在诊断时 (D0) 和30天后 (D30) 测量9个生物标志物的血水平.
- 对患者人口统计学,临床数据和生物标志物度的分析,将DVT组与对照组进行比较,以及被挑起/未被挑起的子组之间的比较.
主要成果:
- 与对照组相比,在D0的DVT患者中观察到D-二聚合物,·威勒布兰德因子,C反应蛋白和Anti-Xa的血清度升高.
- 在诊断时或诊断后30天,在被诱导和未被诱导的DVT组之间没有发现生物标志物水平的显著差异.
- 在30天的研究期间,诱导DVT组在生物标志物度中显示出显著的时间变化.
结论:
- 虽然某些生物标志物在DVT中升高,但目前的分子概况并不能显著区分被诱导和未被诱导的病例.
- 诱导组中的时间生物标志物变化表明了动态评估的潜力.
- 需要对更大的队列进行进一步的研究,以验证这些发现,并确定分子标记物在个性化VTE管理中的作用.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
144
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
144
01:24Disorders of Hemostasis
885
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
885
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
81
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
81